Publicações

Lmo2 Protein Expression Predicts Survival in Patients with Diffuse Large B-Cell Lymphoma Treated with Anthracycline-Based Chemotherapy with and Without Rituximab

AuthID
P-009-E3Y

Author(s)

Natkunam, Y

Farinha, P

Hsi, ED

Hans, CP

Tibshirani, R

Sehn, LH

Connors, JM

Gratzinger, D

Rosado, M

Zhao, S

Pohlman, B

Wongchaowart, N

Bast, M

Avigdor, A

Schiby, G

Nagler, A

Byrne, GE

Levy, R

Gascoyne, RD

Lossos, IS

Document Type

Article

Year published

2008

Published

in Journal of Clinical Oncology, ISSN: 0732-183X

Volume: 26, Issue: 3, Pages: 447-454

Indexing

Scopus^®

Crossref^®

Pubmed^®

Google Scholar^®

Metadata
Sources

Publication Identifiers

DOI: 10.1200/jco.2007.13.0690

Pubmed: 18086797

Scopus: 2-s2.0-38649123973

Source Identifiers

ISSN: 0732-183X

Export Publication Metadata

Lista Marked

Adicionar à lista Marked

Info

At this moment we don't have any links to full text documens.

Lmo2 Protein Expression Predicts Survival in Patients with Diffuse Large B-Cell Lymphoma Treated with Anthracycline-Based Chemotherapy with and Without Rituximab

Useful Links

Get Help

Autenticação Federada (Click on the image)

Lmo2 Protein Expression Predicts Survival in Patients with Diffuse Large B-Cell Lymphoma Treated with Anthracycline-Based Chemotherapy with and Without Rituximab

Useful Links

Get Help